| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/12/2004 | US20040157861 Compositions and methods for inhibiting TGF-beta |
| 08/12/2004 | US20040157858 Piperazine derivatives as tachykinin antagonists |
| 08/12/2004 | US20040157857 Substituted chroman derivatives |
| 08/12/2004 | US20040157843 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/12/2004 | US20040157830 Formailide derivatives as beta2-adrenoreceptor agonists |
| 08/12/2004 | US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/12/2004 | US20040157812 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/12/2004 | US20040157806 4-Dedimethylamino tetracycline compounds |
| 08/12/2004 | US20040157785 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040157772 Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis |
| 08/12/2004 | US20040157302 exhibiting inhibitory activity against lanosterol synthase for preventive and therapeutic agents caused by accumulation of cholesterol in humans and antifungal agents; using streptomyces |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157259 Novel human ion channel protein and polynucleotides encoding the same |
| 08/12/2004 | US20040157250 Contacting a test compound with an expression system comprising an ABCA1 polynucleotide and detecting a change; use in treating coronary artery disease |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040157207 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander |
| 08/12/2004 | US20040157073 Lubricious coatings for substrates |
| 08/12/2004 | US20040156915 releasing a mixture of blood-dispersible gas and aqueous sclerosant liquid in a container, to effect interaction of the components to form a microfoam; used to eliminate varicose veins and other disorders involving venous malformation |
| 08/12/2004 | US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner |
| 08/12/2004 | US20040156887 Stabilized dispersion of phytosterol in oil |
| 08/12/2004 | US20040156859 GP-41 peptides, BBB peptides, anticancer agents, antihistamines, bronchodilators, hypotensive agents, antiangina agents, opioids, analgesics, antidepressants, and hypothyroid agents reactive with amino, hydroxyl or thiol groups |
| 08/12/2004 | US20040156827 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 08/12/2004 | US20040156787 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic theraphy and in vivo diagnostic |
| 08/12/2004 | US20040156783 Complexes of cyanine, indocyanine, phthalocyanine, rhodamine, oxazine, thiazine, phenoselenazines, fluoresceins, porphyrin, squaraine, corrins, croconium, azo, methine and/or indolenium dye linked with receptor binding molecules; tumors |
| 08/12/2004 | CA2514575A1 Crystal of (23s)-1.alpha.-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same |
| 08/12/2004 | CA2514547A1 Receptor agonists |
| 08/12/2004 | CA2513699A1 Means for regulating the expression of human isoforms of ant |
| 08/12/2004 | CA2513641A1 Substituted heterocyclic compounds |
| 08/12/2004 | CA2511941A1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/11/2004 | EP1445258A1 Activator for peroxisome proliferator-activated receptor delta |
| 08/11/2004 | EP1445256A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient |
| 08/11/2004 | EP1445250A1 Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same |
| 08/11/2004 | EP1444981A1 Intracellular calcium concentration increase inhibitors |
| 08/11/2004 | EP1444329A2 Stem cells that transform to beating cardiomyocytes |
| 08/11/2004 | EP1444267A2 Affinity enhancement agents |
| 08/11/2004 | EP1444265A2 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 08/11/2004 | EP1444251A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 08/11/2004 | EP1444235A1 Reverse-turn mimetics and method relating thereto |
| 08/11/2004 | EP1444234A2 Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 08/11/2004 | EP1444233A2 A 2b? adenosine receptor antagonists |
| 08/11/2004 | EP1444232A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase |
| 08/11/2004 | EP1444231A1 Amine salts of an integrin receptor antagonist |
| 08/11/2004 | EP1444229A1 Pyrazole derivatives as psychopharmaceuticals |
| 08/11/2004 | EP1444227A1 Thiazolyl substituted triazoles as alk5 inhibitors |
| 08/11/2004 | EP1444226A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 08/11/2004 | EP1444219A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor |
| 08/11/2004 | EP1444212A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds |
| 08/11/2004 | EP1444210A1 Qunazoline derivatives as antitumor agents |
| 08/11/2004 | EP1444209A2 Mitotic kinesin inhibitors |
| 08/11/2004 | EP1444203A1 Cannabinoid receptor ligands |
| 08/11/2004 | EP1444202A1 Novel metalloproteinase inhibitors |
| 08/11/2004 | EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 08/11/2004 | EP1444009A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors |
| 08/11/2004 | EP1443972A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 08/11/2004 | EP1443970A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 08/11/2004 | EP1443962A2 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443956A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 08/11/2004 | EP1443953A2 Detection and treatment of intravascular lesions |
| 08/11/2004 | EP1443948A1 Process for the preparation of anthocyanin-containing products |
| 08/11/2004 | EP1443946A2 Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
| 08/11/2004 | EP1443939A1 Compositions for treatment of postmenopausal female sexual dysfunction |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443931A1 Methods for treating neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicaments |
| 08/11/2004 | EP1443929A2 Treatment of cns disorders using cns target modulators |
| 08/11/2004 | EP1443925A1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 08/11/2004 | EP1443924A1 4-[3,5-bis-(2-hydroxy-phenyl)-[1,2,4]triazol-1-yl]-benzoic acid derivatives for treating an excess of metal in the body |
| 08/11/2004 | EP1443923A1 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 08/11/2004 | EP1443922A1 Mch antagonists for the treatment of obesity |
| 08/11/2004 | EP1443916A1 Pharmaceutical composition comprising an adenosine a1/a2 agonist and a sodium hydrogen exchanger inhibitor |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443861A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 08/11/2004 | EP1443860A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 08/11/2004 | EP1443816A2 Methods of treating disorders related to apoe |
| 08/11/2004 | EP1360182B1 4-aminobenzopyran derivatives |
| 08/11/2004 | EP1358182B1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/11/2004 | EP1315708B1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 08/11/2004 | EP1155003B1 Novel guanidine derivatives as inhibitors of cell adhesion |
| 08/11/2004 | EP1154988B1 Mevinolin derivatives |
| 08/11/2004 | EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 08/11/2004 | EP1140918B1 Thrombin inhibitors |
| 08/11/2004 | EP1135381B1 Eletriptan hydrobromide monohydrate |
| 08/11/2004 | EP1109813B1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/11/2004 | EP1080075B1 Piperididinyl and n-amidinopiperidinyl derivatives |
| 08/11/2004 | EP1012329A4 Diagnosis and treatment of myocardial failure |
| 08/11/2004 | EP1003776B1 Screening method using FREAC-11 transcription factor |
| 08/11/2004 | EP0937047B1 1-arylphthalazine antagonists of excitatory amino acid receptors |
| 08/11/2004 | EP0852491B1 Use of heparinases to decrease inflammatory responses |
| 08/11/2004 | EP0821728B1 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2004 | EP0575464B1 Modified factor vii |
| 08/11/2004 | CN1520417A New process for prepn. of oxabispidines |
| 08/11/2004 | CN1520416A 碳水化合物衍生物 Carbohydrate derivatives |
| 08/11/2004 | CN1520414A Novel compound, its prepn. and application |
| 08/11/2004 | CN1520410A Novel heteroaryl derivatives, their prepn. and use |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520408A Piperazine compounds |
| 08/11/2004 | CN1520406A Substituted benzopyran derivatives aganst arrhythmia |